Form 4: AtriCure CEO Michael Carrel Reports Gift of Shares to Children
SEC Form 4 Filing
AtriCure's CEO, Michael Carrel, reported a gift of 2,000 shares of common stock to his children on March 14, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 14, 2024, Michael H. Carrel, the President, CEO, and Director of AtriCure, Inc. (ATRC), gifted 2,000 shares of AtriCure common stock to his children.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
- Following the transaction, Carrel directly owns 655,532 shares of AtriCure common stock.
- Carrel also indirectly owns 5,310 shares held by his children and 2,250 shares held by his parents, but disclaims beneficial ownership except for his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a gift of shares, and does not inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a gift and does not involve a sale or purchase in the open market.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of the gift transaction of AtriCure common stock. |
| 03/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.